4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-044370
CEO and Chairman sold 54,028 shares at an average $37.74 ($2,039,237)
- CEO and Chairman acquired 54,028 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-07-29 | Option exercise | +20,668 | $0.33 | $6,820 | 1,798,848 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-29 | Sale | −20,668 | $38.14 | $788,278 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-30 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-30 | Sale | −6,796 | $37.48 | $254,714 | 1,788,064 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-30 | Sale | −9,884 | $37.96 | $375,197 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-31 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-31 | Sale | −15,480 | $37.19 | $575,701 | 1,779,380 | D |
| ROBINS CHAD M CEO and Chairman | 2020-07-31 | Sale | −1,200 | $37.79 | $45,348 | 1,778,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-07-29 | Option exercise · Stock Option (Right to Buy) | −20,668 | 328,080 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-07-30 | Option exercise · Stock Option (Right to Buy) | −16,680 | 311,400 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-07-31 | Option exercise · Stock Option (Right to Buy) | −16,680 | 294,720 | D | ||
| Open-market sales · 54,028 sh · avg $37.74 · $2,039,237 | |||||||
Loading xslF345X03/doc4.xml…